Average Co-Inventor Count = 5.66
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (9 from 2,405 patents)
2. Merck + Co., Inc. (6 from 4,770 patents)
3. Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa (1 from 47 patents)
15 patents:
1. 8591878 - Therapeutic compounds
2. 8461107 - HCV NS3 protease inhibitors
3. 8338449 - Isoquinolinone potassium channel inhibitors
4. 8216999 - HCV NS3 protease inhibitors
5. 7781457 - Isoquinolinone potassium channel inhibitors
6. 7763614 - Isoquinoline potassium channel inhibitors
7. 7741322 - Isoquinolinone potassium channel inhibitors
8. 7723352 - Isoquinolinone potassium channel inhibitors
9. 7709476 - Isoquinolinone potassium channel inhibitors
10. 7470664 - HCV NS3 protease inhibitors
11. 7452893 - 4-cycloakylaminopyrazolo pyrimidine NMDA/NR2B antagonists
12. 7259157 - N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists
13. 7196095 - (Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds
14. 6870055 - Isoquinolinone potassium channels inhibitors
15. 6602872 - Substituted pyridazines having cytokine inhibitory activity